135 related articles for article (PubMed ID: 15167707)
1. Differential transcriptional expresión of the polymorphic myxovirus resistance protein A in response to interferon-alpha treatment.
Fernández-Arcás N; Blanco A; Gaitán MJ; Nyqvist M; Alonso A; Reyes-Engel A
Pharmacogenetics; 2004 Mar; 14(3):189-93. PubMed ID: 15167707
[TBL] [Abstract][Full Text] [Related]
2. MxA induction may predict sustained virologic responses of chronic hepatitis B patients with IFN-alpha treatment.
Kong XF; Zhang XX; Gong QM; Gao J; Zhang SY; Wang L; Xu J; Han Y; Jin GD; Jiang JH; Zhang DH; Lu ZM
J Interferon Cytokine Res; 2007 Sep; 27(9):809-18. PubMed ID: 17892402
[TBL] [Abstract][Full Text] [Related]
3. Association of Myxovirus Resistance Gene Promoter Polymorphism with Response to Combined Interferon Treatment and Progression of Liver Disease in Chronic HCV Egyptian Patients.
Bader El Din NG; Salum GM; Anany MA; Ibrahim MK; Dawood RM; Zayed N; El Abd YS; El-Shenawy R; El Awady MK
J Interferon Cytokine Res; 2015 Aug; 35(8):641-8. PubMed ID: 25868067
[TBL] [Abstract][Full Text] [Related]
4. [Genetic polymorphisms of MxA protein and eIF-2a-reg2 and their responses to interferon treatment in patients with chronic hepatitis B].
Huang YX; Ma LN; Chen XY; Li Z; Huang YL; Shen CL; Ma B
Zhonghua Gan Zang Bing Za Zhi; 2007 Mar; 15(3):187-91. PubMed ID: 17407708
[TBL] [Abstract][Full Text] [Related]
5. Identification of a single nucleotide polymorphism in the MxA gene promoter (G/T at nt -88) correlated with the response of hepatitis C patients to interferon.
Hijikata M; Ohta Y; Mishiro S
Intervirology; 2000; 43(2):124-7. PubMed ID: 10971132
[TBL] [Abstract][Full Text] [Related]
6. Correlation of interferon-induced expression of MxA mRNA in peripheral blood mononuclear cells with the response of patients with chronic active hepatitis C to IFN-alpha therapy.
Antonelli G; Simeoni E; Turriziani O; Tesoro R; Redaelli A; Roffi L; Antonelli L; Pistello M; Dianzani F
J Interferon Cytokine Res; 1999 Mar; 19(3):243-51. PubMed ID: 10213463
[TBL] [Abstract][Full Text] [Related]
7. [Association between single nucleotide polymorphisms in -88 and -123 loci of MxA gene promoter region and HCV susceptibility and IFN-α efficacy].
Hu CH; Chen J; Yang R; Li NN; Yang B; Ma D; Liang XC; Wang Q
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Dec; 28(12):1307-10. PubMed ID: 23232524
[TBL] [Abstract][Full Text] [Related]
8. The proximal interferon-stimulated response elements are essential for interferon responsiveness: a promoter analysis of the antiviral MxA gene.
Ronni T; Matikainen S; Lehtonen A; Palvimo J; Dellis J; Van Eylen F; Goetschy JF; Horisberger M; Content J; Julkunen I
J Interferon Cytokine Res; 1998 Sep; 18(9):773-81. PubMed ID: 9781817
[TBL] [Abstract][Full Text] [Related]
9. Significance of the myxovirus resistance A (MxA) gene -123C>a single-nucleotide polymorphism in suppressed interferon beta induction of severe acute respiratory syndrome coronavirus infection.
Ching JC; Chan KY; Lee EH; Xu MS; Ting CK; So TM; Sham PC; Leung GM; Peiris JS; Khoo US
J Infect Dis; 2010 Jun; 201(12):1899-908. PubMed ID: 20462354
[TBL] [Abstract][Full Text] [Related]
10. Single nucleotide polymorphism of the MxA gene promoter influences the response to interferon monotherapy in patients with hepatitis C viral infection.
Suzuki F; Arase Y; Suzuki Y; Tsubota A; Akuta N; Hosaka T; Someya T; Kobayashi M; Saitoh S; Ikeda K; Kobayashi M; Matsuda M; Takagi K; Satoh J; Kumada H
J Viral Hepat; 2004 May; 11(3):271-6. PubMed ID: 15117331
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms in interferon-induced genes and the outcome of hepatitis C virus infection: roles of MxA, OAS-1 and PKR.
Knapp S; Yee LJ; Frodsham AJ; Hennig BJ; Hellier S; Zhang L; Wright M; Chiaramonte M; Graves M; Thomas HC; Hill AV; Thursz MR
Genes Immun; 2003 Sep; 4(6):411-9. PubMed ID: 12944978
[TBL] [Abstract][Full Text] [Related]
12. Functional MxA promoter polymorphism associated with subacute sclerosing panencephalitis.
Torisu H; Kusuhara K; Kira R; Bassuny WM; Sakai Y; Sanefuji M; Takemoto M; Hara T
Neurology; 2004 Feb; 62(3):457-60. PubMed ID: 14872030
[TBL] [Abstract][Full Text] [Related]
13. IL28 variation affects expression of interferon stimulated genes and peg-interferon and ribavirin therapy.
Abe H; Hayes CN; Ochi H; Maekawa T; Tsuge M; Miki D; Mitsui F; Hiraga N; Imamura M; Takahashi S; Kubo M; Nakamura Y; Chayama K
J Hepatol; 2011 Jun; 54(6):1094-101. PubMed ID: 21145800
[TBL] [Abstract][Full Text] [Related]
14. Interferon regulatory factor-1 promoter polymorphism and the outcome of hepatitis C virus infection.
Wietzke-Braun P; Maouzi AB; Mänhardt LB; Bickeböller H; Ramadori G; Mihm S
Eur J Gastroenterol Hepatol; 2006 Sep; 18(9):991-7. PubMed ID: 16894313
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B virus downregulates the human interferon-inducible MxA promoter through direct interaction of precore/core proteins.
Fernández M; Quiroga JA; Carreño V
J Gen Virol; 2003 Aug; 84(Pt 8):2073-2082. PubMed ID: 12867637
[TBL] [Abstract][Full Text] [Related]
16. Association of TRIM22 with the type 1 interferon response and viral control during primary HIV-1 infection.
Singh R; Gaiha G; Werner L; McKim K; Mlisana K; Luban J; Walker BD; Karim SS; Brass AL; Ndung'u T;
J Virol; 2011 Jan; 85(1):208-16. PubMed ID: 20980524
[TBL] [Abstract][Full Text] [Related]
17. MxA expression as marker for assessing the therapeutic response in HCV genotype 4 Egyptian patients.
Shaker O; Ahmed A; Doss W; Abdel-Hamid M
J Viral Hepat; 2010 Nov; 17(11):794-9. PubMed ID: 20002306
[TBL] [Abstract][Full Text] [Related]
18. Functional characterization of new allelic polymorphisms identified in the promoter region of the human MxA gene.
Tran Thi Duc T; Desmecht D; Cornet A
Int J Immunogenet; 2013 Aug; 40(4):316-9. PubMed ID: 22985419
[TBL] [Abstract][Full Text] [Related]
19. MxA transcripts with distinct first exons and modulation of gene expression levels by single-nucleotide polymorphisms in human bronchial epithelial cells.
Noguchi S; Hijikata M; Hamano E; Matsushita I; Ito H; Ohashi J; Nagase T; Keicho N
Immunogenetics; 2013 Feb; 65(2):107-14. PubMed ID: 23160781
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of myxovirus-resistance protein A: a possible marker of type I interferon induction in systemic sclerosis.
Airò P; Ghidini C; Zanotti C; Scarsi M; Cattaneo R; Caimi L; Imberti L
J Rheumatol; 2008 Nov; 35(11):2192-200. PubMed ID: 18843779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
